Europe Cancer Immunotherapy Market by Application - (Breast, Lung, Melanoma, Colorectal, Head & Neck, Prostate and others), by Product Type – (Monoclonal Antibodies, Checkpoint inhibitors/immune modulators, Therapeutic cancer vaccines, Oncolytic virus immunotherapy, Cytokines, Adoptive T cell transfer, Adjuvant Immunotherapy, Interferons, Interleukins, BCG and others) by Mode of Administration – (Intravenous, Oral, Topical, Intravesical), by End users (Hospitals, Clinics) and by Region - Industry Analysis, Size, Share, Growth, Trends, and Forecasts (2016–2021)

Europe Cancer Immunotherapy Market by Application - (Breast, Lung, Melanoma, Colorectal, Head & Neck, Prostate and others), by Product Type – (Monoclonal Antibodies, Checkpoint inhibitors/immune modulators, Therapeutic cancer vaccines, Oncolytic virus immunotherapy, Cytokines, Adoptive T cell transfer, Adjuvant Immunotherapy, Interferons, Interleukins, BCG and others) by Mode of Administration – (Intravenous, Oral, Topical, Intravesical), by End users (Hospitals, Clinics) and by Region - Industry Analysis, Size, Share, Growth, Trends, and Forecasts (2016–2021)

ID: 1414 | Pages: 132 | November 2016 | Region: Europe


The Europe Cancer Immunotherapy Market was worth $ 13.02 Billion in 2016 and estimated to reach $ 23.41 Billion by the end of 2021 with a growing potential of 12.45 %.

Healing of disease by inducing and improving immune response for the prevention of disease is termed as immunotherapy. Cancer immunotherapy is an activation immunotherapy. Immune system is a compilation of special cells, organs that defend the body from infections and other diseases, and safeguard from cancer in many ways. The immune system keeps path of all substances found in body. The immune response can destroy everything containing the foreign matter, such as microbes or cancer cells.

Europe cancer immunotherapy Market is mainly driven by factors such as increasing occurrence of cancer, Changing life style, Smoking and excessive alcoholic intake, high efficacy of immunotherapy compared to other treatments, less side effects associated with cancer immunotherapy, reduced chance of recurrence of cancer. Various cancers like Melanoma shows resistance towards chemotherapy and radiation therapies, Cost of cancer therapies, limited information on cancer immunobiology are the major factor challenging the growth of the market.

Europe Cancer immunotherapy market is segmented based on Application into Breast, Lung, Melanoma, Colorectal, Head & Neck, Prostate and others. Based on product type, the market is segmented into Monoclonal Antibodies, Checkpoint inhibitors/immune modulators, Therapeutic cancer vaccines, Oncolytic virus immunotherapy, Cytokines, Adoptive T cell transfer, Adjuvant Immunotherapy, BCG and others. Based on Mode of administration, the market is segmented into Intravenous, Oral, Topical, and Intravesical. Based on end users, the market is categorized into hospitals, clinics. Based on Geography, the Europe Cancer immunotherapy market is analysed under various regions namely U.K, Germany, France, Italy and Spain.

Some of the major companies dominating Europe cancer immunotherapy Market are F. Hoffmann-La Roche Ltd, Amgen, Viralytics, Novartis Pharmaceuticals Corporation, Pfizer, GlaxoSmithKline Pharmaceuticals Limited, AstraZeneca plc, Medivation, Advaxis, Bristol-Myers Squibb, Merck & Co. and Celgene Corp, Immunomedics.

1.Introduction                                  

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                           

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                              

                2.2 Research Phases                      

                                2.2.1 Secondary Research            

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling     

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                      

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemology                             

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                      

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market               

5. Market Segmentation                                              

                5.1 Application                 

                                5.1.1 Introduction           

                                5.1.2 Breast       

                                5.1.3 Lung          

                                5.1.4 Melanoma              

                                5.1.5 Colorectal

                                5.1.6 Head & Neck          

                                5.1.7 Prostate   

                                5.1.8 Others      

                                5.1.9 Y-o-Y Growth Analysis, By Application         

                                5.1.10 Market Attractiveness Analysis, By Application     

                                5.1.11 Market Share Analysis, By Application      

                5.2 Product Type                             

                                5.2.1 Introduction           

                                5.2.2 Monoclonal Antibodies     

                                5.2.3 Checkpoint inhibitors/immune modulators              

                                5.2.4 Therapeutic cancer vaccines            

                                5.2.5 Oncolytic virus immunotherapy     

                                5.2.6 Cytokines

                                5.2.7 Adoptive T cell transfer     

                                5.2.8 Adjuvant Immunotherapy

                                5.2.9 Interferons             

                                5.2.10 Interleukins         

                                5.2.11 BCG         

                                5.2.12 Others   

                                5.2.13 Y-o-Y Growth Analysis, By Product Type   

                                5.2.14 Market Attractiveness Analysis, By Product Type

                                5.2.15 Market Share Analysis, By Product Type  

                5.3 Mode of Administration                        

                                5.3.1 Introduction           

                                5.3.2 Intravenous           

                                5.3.3 Oral            

                                5.3.4 Topical      

                                5.3.5 Intra Vesical           

                                5.3.6 Y-o-Y Growth Analysis, By Mode of Administration

                                5.3.7 Market Attractiveness Analysis, By Mode of Administration              

                                5.3.8 Market Share Analysis, By Mode of Administration

                5.3 End users                    

                                5.3.1 Introduction           

                                5.3.2 Hospitals  

                                5.3.3 Clinics        

                                5.3.4 Y-o-Y Growth Analysis, By End users            

                                5.3.5 Market Attractiveness Analysis, By End users           

                                5.3.6 Market Share Analysis, By End users            

6. Geographical Analysis                                              

                6.1 Introduction                              

                                6.1.1 Regional Trends    

                                6.1.2 Impact Analysis     

                                6.1.3 Y-o-Y Growth Analysis        

                                                6.1.3.1 By Geographical Area

                                                6.1.3.2 By Application

                                                6.1.3.3 By Product Type

                                                6.1.3.4 By Mode of Administration

                                                6.1.3.5 By End users

                                6.1.4 Market Attractiveness Analysis      

                                                6.1.4.1 By Geographical Area

                                                6.1.4.2 By Application

                                                6.1.4.3 By Product Type

                                                6.1.4.4 By Mode of Administration

                                                6.1.4.5 By End users

                                6.1.5 Market Share Analysis        

                                                6.1.5.1 By Geographical Area

                                                6.1.5.2 By Application

                                                6.1.5.3 By Product Type

                                                6.1.5.4 By Mode of Administration

                                                6.1.5.6 By End users

                6.2 U.K                

                6.3 Spain                             

                6.4 Germany                     

                6.5 Italy                               

                6.6 France                          

7.Strategic Analysis                                        

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental      

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services

                                7.2.5 Competitive Rivalry within the Industry      

8.Market Leaders' Analysis                                          

                8.1 F. Hoffmann-La Roche Ltd                    

                                8.1.1 Overview

                                8.1.2 Product Analysis   

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 Amgen                         

                8.3 Viralytics                      

                8.4 Novartis Pharmaceuticals Corporation                            

                8.5 Pfizer                            

                8.6 GlaxoSmithKline Pharmaceuticals Limited                     

                8.7 AstraZeneca plc                        

                8.8 Medivation                

                8.9 Advaxis                        

                8.10 Bristol-Myers Squibb                           

                8.11 Merck & Co. and Celgene Corp                        

                8.12 Immunomedics                      

9.Competitive Landscape                                            

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                        

                9.3 Agreements, collaborations and Joint Ventures                          

                9.4 New Product Launches                          

10.Market Outlook and Investment Opportunities                                           

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
TitlePriceAdd To Cart
  1. Europe Cancer Immunotherapy Market By Application, From 2016-2021 ( USD Billion )
  2. Europe Breast Market By Region, From 2016-2021 ( USD Billion )
  3. Europe Lung Market By Region, From 2016-2021 ( USD Billion )
  4. Europe Melanoma Market By Region, From 2016-2021 ( USD Billion )
  5. Europe Colorectal Market By Region, From 2016-2021 ( USD Billion )
  6. Europe Head & Neck Market By Region, From 2016-2021 ( USD Billion )
  7. Europe Prostate Market By Region, From 2016-2021 ( USD Billion )
  8. Europe Cancer Immunotherapy Market By Product Type, From 2016-2021 ( USD Billion )
  9. Europe Monoclonal Antibodies Market By Region, From 2016-2021 ( USD Billion )
  10. Europe Checkpoint inhibitors/immune modulators Market By Region, From 2016-2021 ( USD Billion )
  11. Europe Therapeutic cancer vaccines Market By Region, From 2016-2021 ( USD Billion )
  12. Europe Oncolytic virus immunotherapy Market By Region, From 2016-2021 ( USD Billion )
  13. Europe Cytokines Market By Region, From 2016-2021 ( USD Billion )
  14. Europe Adoptive T cell Transfer Market By Region, From 2016-2021 ( USD Billion )
  15. Europe Adjuvant immunotherapy Market By Region, From 2016-2021 ( USD Billion )
  16. Europe Interferons Market By Region, From 2016-2021 ( USD Billion )
  17. Europe Interleukins Market By Region, From 2016-2021 ( USD Billion )
  18. Europe BCG Market By Region, From 2016-2021 ( USD Billion )
  19. Europe Cancer Immunotherapy Market By Mode of Administration, From 2016-2021 ( USD Billion )
  20. Europe Intravenous Market By Region, From 2016-2021 ( USD Billion )
  21. Europe Oral Market By Region, From 2016-2021 ( USD Billion )
  22. Europe Topical Market By Region, From 2016-2021 ( USD Billion )
  23. Europe Intravesical Market By Region, From 2016-2021 ( USD Billion )
  24. Europe Cancer Immunotherapy Market By End users, From 2016-2021 ( USD Billion )
  25. Europe hospitals Market By Region, From 2016-2021 ( USD Billion )
  26. Europe Clinics Market By Region, From 2016-2021 ( USD Billion )
  27. U.K. Cancer Immunotherapy Market By Application, From 2016-2021 ( USD Billion )
  28. U.K. Cancer Immunotherapy Market By Product Type, From 2016-2021 ( USD Billion )
  29. U.K. Cancer Immunotherapy Market By Mode of Administration, From 2016-2021 ( USD Billion )
  30. U.K. Cancer Immunotherapy Market By End users, From 2016-2021 ( USD Billion )
  31. Germany Cancer Immunotherapy Market By Application, From 2016-2021 ( USD Billion )
  32. Germany Cancer Immunotherapy Market By Product Type, From 2016-2021 ( USD Billion )
  33. Germany Cancer Immunotherapy Market By Mode of Administration, From 2016-2021 ( USD Billion )
  34. Germany Cancer Immunotherapy Market By End users, From 2016-2021 ( USD Billion )
  35. France Cancer Immunotherapy Market By Application, From 2016-2021 ( USD Billion )
  36. France Cancer Immunotherapy Market By Product Type, From 2016-2021 ( USD Billion )
  37. France Cancer Immunotherapy Market By Mode of Administration, From 2016-2021 ( USD Billion )
  38. France Cancer Immunotherapy Market By End users, From 2016-2021 ( USD Billion )
  39. Italy Cancer Immunotherapy Market By Application, From 2016-2021 ( USD Billion )
  40. Italy Cancer Immunotherapy Market By Product Type, From 2016-2021 ( USD Billion )
  41. Italy Cancer Immunotherapy Market By Mode of Administration, From 2016-2021 ( USD Billion )
  42. Italy Cancer Immunotherapy Market By End users, From 2016-2021 ( USD Billion )
  43. Spain Cancer Immunotherapy Market By Application, From 2016-2021 ( USD Billion )
  44. Spain Cancer Immunotherapy Market By Product Type, From 2016-2021 ( USD Billion )
  45. Spain Cancer Immunotherapy Market By Mode of Administration, From 2016-2021 ( USD Billion )
  46. Spain Cancer Immunotherapy Market By End users, From 2016-2021 ( USD Billion )

"We Think Through Different Layers, We Work Across Different Verticals."

Market Data Forecast, Inc.
502, Kakatiya's Empire,
Jubilee Gardens, Hyderabad,
Telangana, India.
+1-888-702-9626 (U.S. TOLL FREE)
contact@marketdataforecast.com


Subscribe To Our News Letter

Or follow us on social platform

© 2017 Market Data Forecast
All Rights Reserved.